Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
Intravitreal injection of a therapeutic substance is the most common procedure performed in ophthalmology. It has a low incidence of serious complications but is associated with a small chance of endophthalmitis. Although the rate of endophthalmitis is between 0.019% and 0.09%, the associated visual...
Saved in:
Main Authors: | P. ET. Lau, K. S. Jenkins, C. J. Layton |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2018/8567912 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sterile Endophthalmitis after Intravitreal Injections
by: Joaquín Marticorena, et al.
Published: (2012-01-01) -
Erratum to “Sterile Endophthalmitis after Intravitreal Injections”
by: Joaquín Marticorena, et al.
Published: (2013-01-01) -
Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes
by: Ana Maria Cunha, et al.
Published: (2021-01-01) -
Intravitreal Dexamethasone in the Management of Delayed-Onset Bleb-Associated Endophthalmitis
by: David J. Jacobs, et al.
Published: (2012-01-01) -
The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury
by: Xiao Zhao, et al.
Published: (2021-01-01)